K. L. Kirk, A. Buku, and P. Eggena, Cell specificity of vasopressin binding in renal collecting duct: computer-enhanced imaging of a fluorescent hormone analog., Proceedings of the National Academy of Sciences, vol.84, issue.16, p.6000, 1987.
DOI : 10.1073/pnas.84.16.6000

A. Buku and N. Yamin, Fluorescent, photoaffinity, and biotinyl analogs of oxytocin, Peptides, vol.9, issue.4, pp.783-805, 1988.
DOI : 10.1016/0196-9781(88)90122-2

A. Buku and D. Gazis, Probes for vasopressin receptors Attachment of affinity and fluorescent groups in vasopressin, International Journal of Peptide and Protein Research, vol.30, issue.145, p.128, 1990.
DOI : 10.1111/j.1399-3011.1990.tb00247.x

J. Howl, D. C. New, and M. Wheatley, Design and synthesis of heterofunctional V1a-selective vasopressin receptor ligands with lysine at position 9, Journal of Molecular Endocrinology, vol.9, issue.2, p.123, 1992.
DOI : 10.1677/jme.0.0090123

J. Howl, X. Wang, C. J. Kirk, and M. Wheatley, Fluorescent and biotinylated linear peptides as selective bifunctional ligands for the V1a vasopressin receptor, European Journal of Biochemistry, vol.171, issue.2, p.711, 1993.
DOI : 10.1016/0006-8993(88)91437-0

E. Kojro, P. Eich, G. Gimpl, and F. Fahrenholz, Direct identification of an extracellular agonist binding site in the renal V2 vasopressin receptor, Biochemistry, vol.32, issue.49, p.13537, 1993.
DOI : 10.1021/bi00212a020

R. Postina, E. Kojro, and F. Fahrenholz, Separate Agonist and Peptide Antagonist Binding Sites of the Oxytocin Receptor Defined by Their Transfer into the V2 Vasopressin Receptor, Journal of Biological Chemistry, vol.271, issue.49, p.31593, 1996.
DOI : 10.1074/jbc.271.49.31593

S. R. Hawtin, V. J. Wesley, R. A. Parslow, J. Simms, A. Miles et al., Vasopressin Receptor Is Critical for Binding Vasopressin But Not Peptide or Nonpeptide Antagonists, Molecular Endocrinology, vol.16, issue.3, p.600, 2002.
DOI : 10.1210/mend.16.3.0795

W. Lutz, M. Sanders, J. Salisbury, and R. Kumar, Internalization of vasopressin analogs in kidney and smooth muscle cells: evidence for receptor-mediated endocytosis in cells with V2 or V1 receptors., Proceedings of the National Academy of Sciences, vol.87, issue.17, p.6507, 1990.
DOI : 10.1073/pnas.87.17.6507

M. Allen, J. Reeves, and G. Mellor, High Throughput Fluorescence Polarization: A Homogeneous Alternative to Radioligand Binding for Cell Surface Receptors, Journal of Biomolecular Screening, vol.37, issue.2, p.63, 2000.
DOI : 10.1177/108705710000500202

J. G. Verbalis, AVP receptor antagonists as aquaretics: review and assessment of clinical data., Cleveland Clinic Journal of Medicine, vol.73, issue.Suppl_3, p.24, 2006.
DOI : 10.3949/ccjm.73.Suppl_3.S24

S. Nakayama, K. Sekiguchi, T. Kambe, G. Tsujimoto, T. Mori et al., -agonist, OPC-51803, in cells transfected human vasopressin receptor subtypes, British Journal of Pharmacology, vol.105, issue.Suppl. 2, p.1700, 2000.
DOI : 10.1038/sj.bjp.0703221
URL : https://hal.archives-ouvertes.fr/in2p3-00409176

G. R. Pitt, A. R. Batt, R. M. Haigh, A. M. Penson, P. A. Robson et al., Non-peptide oxytocin agonists, Bioorganic & Medicinal Chemistry Letters, vol.14, issue.17, p.4585, 2004.
DOI : 10.1016/j.bmcl.2004.04.107

C. J. Daly and J. C. Mcgrath, Fluorescent ligands, antibodies, and proteins for the study of receptors, Pharmacology & Therapeutics, vol.100, issue.2, p.101, 2003.
DOI : 10.1016/j.pharmthera.2003.08.001

R. J. Middleton and B. Kellam, Fluorophore-tagged GPCR ligands, Current Opinion in Chemical Biology, vol.9, issue.5, p.517, 2005.
DOI : 10.1016/j.cbpa.2005.08.016

S. J. Briddon and S. J. Hill, Pharmacology under the microscope: the use of fluorescence correlation spectroscopy to determine the properties of ligand???receptor complexes, Trends in Pharmacological Sciences, vol.28, issue.12, p.637, 2007.
DOI : 10.1016/j.tips.2007.09.008

H. L. Handl and R. J. Gillies, Lanthanide-based luminescent assays for ligand-receptor interactions, Life Sciences, vol.77, issue.4, p.361, 2005.
DOI : 10.1016/j.lfs.2005.01.009